Jean Godin holds a Doctorate in Medicine (MD) from the University of Montreal, a post Graduate diploma in Family Medicine from the University of Montreal, a MBA in Business Administration from McGill University and is a licensed physician of the Quebec College of Physician & Medical Council of Canada (LMCC).
He practiced medicine full time in the Montreal area in both university and community hospitals until he joined the pharmaceutical industry in December of 1999.
Jean headed scientific affairs in Canada at Teva Pharmaceuticals (innovative division) from 1999 to 2007. In June 2007, he became General Manager for the branded activities of Teva in Canada; he was then responsible for the development and commercialization of the innovative portfolio.
In July 2012, Jean joined Novartis Canada in the position of Chief Scientific Officer and Vice-President, Clinical and Regulatory Affairs, reporting to the CEO. In that role, he was responsible for medical affairs, regulatory affairs, clinical research, health management, drug safety, medical communications, new product planning and scientific operations. Jean and his team worked across several therapeutic areas His team brought to market 5 new chemical entities and obtained additional indications for already approved products.
Jean has also been a member of the Boards of Directors for BIOQuebec, a biotechnology and life science industry association representing more than 150 member companies and R&D centers in Quebec. He was also on the board of the Quebec Network for Personalized Health Care. Since he joined the industry, Jean has kept a part time medical practice.
Jean joined Sanofi Genzyme on May 16, 2016 in the role of Head, Global MS Medical Affairs Franchise Strategy / Tactics and Product Development and then as Head of Strategic Planning for Medical Affairs, MS & Immunology. He is a member the multiple sclerosis and immunology leadership teams. He currently lives in Cambridge, Massachusetts.